
|Articles|May 31, 2016
Quintiles Introduces Precision Enrollment Offering
Quintiles announces its Precision Enrollment offering to accelerate site start-up and patient recruitment in oncology clinical trials.
Advertisement
Quintiles announces its Precision Enrollment offering to accelerate site start-up and patient recruitment in oncology clinical trials. This new model adjusts the traditional site start-up pathway so that it is only opened after a patient is identified.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Building Broader Investigator Networks to Advance Global Breast Cancer Research
3
AI Offers New Pathways to Strengthen Site Leadership in Underserved Regions
4
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
5






.png)



.png)



.png)
.png)
